QILN HLDG Share Price

Equities

QLI

KYG7307E1070

Market Closed - Nasdaq 21:30:00 26/04/2024 BST 5-day change 1st Jan Change
0.7486 USD -5.12% Intraday chart for QILN HLDG -4.03% -2.96%
Sales 2022 64.86M 5.17B Sales 2023 46.47M 3.71B Capitalization 28.14M 2.25B
Net income 2022 1M 79.79M Net income 2023 -7M -559M EV / Sales 2022 0.46 x
Net cash position 2022 12.55M 1B Net cash position 2023 21.84M 1.74B EV / Sales 2023 0.14 x
P/E ratio 2022
39.7 x
P/E ratio 2023
-3.58 x
Employees 298
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Qilian International Holding Group Limited Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Qilian International Gets Nasdaq Extension to Meet Minimum Bid Price Rule; Shares Rise MT
Qilian International Holding Group Limited Reports Earnings Results for the Half Year Ended March 31, 2023 CI
Qilian International Holding Group Limited Announces Board Changes CI
Qilian International Gets Noncompliance Notice From Nasdaq MT
Qilian International Holding Group Limited Announces Board Changes CI
Qilian International Holding Group Limited Reports Earnings Results for the Full Year Ended September 30, 2022 CI
Qilian International Holding Group Ltd Declares Special Cash Dividend, Payable on or About March 6, 2023 CI
Qilian International Holding Group Limited Reports Earnings Results for the Half Year Ended March 31, 2022 CI
Qilian International Earnings Drop to Breakeven in Latest Six-Month Reporting Period, Revenue Climbs 7% MT
Qilian International Holding Group Limited Announces Board Changes CI
Qilian International Holding Group Limited Intend in 2022 and Beyond to Complete the Construction of a Pig By-Product Processing Facility CI
Qilian International Holding Group Limited Reports Earnings Results for the Full Year Ended September 30, 2021 CI
Qilian International Obtains Approval to Sell Nitrofurantoin Enteric-coated Tablets MT
Qilian International Holding Group Limited Receives Approval for the Sale of Its Newly Developed Nitrofurantoin Enteric-Coated Tablets CI
More news
1 day-5.12%
1 week-4.03%
Current month+8.51%
1 month+8.51%
3 months+36.06%
6 months+26.54%
Current year-2.96%
More quotes
1 week
0.64
Extreme 0.6421
0.82
1 month
0.55
Extreme 0.5501
0.96
Current year
0.36
Extreme 0.3551
0.96
1 year
0.36
Extreme 0.3551
1.28
3 years
0.36
Extreme 0.3551
4.99
5 years
0.36
Extreme 0.3551
22.00
10 years
0.36
Extreme 0.3551
22.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 06/02/19
Director of Finance/CFO 51 07/04/20
Members of the board TitleAgeSince
Director/Board Member 56 12/07/23
Chief Executive Officer 58 06/02/19
Director of Finance/CFO 51 07/04/20
More insiders
Date Price Change Volume
26/04/24 0.7486 -5.12% 12,501
25/04/24 0.789 -0.09% 2,083
24/04/24 0.7897 +7.43% 23,101
23/04/24 0.7351 -3.28% 14,941
22/04/24 0.76 -2.56% 11,915

Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm

More quotes
Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Sector
-
More about the company